Table 1 Relation between DJ-1 and clinicopathological variables in the studied astrocytomas
From: Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors
DJ-1 0 | DJ-1 1 | DJ-1 2 | DJ-1 3 | X 2 | P | Sig | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Row % | N | Row % | N | Row % | N | Row % | |||||
Grade | Grade II | 8 | 28.6% | 17 | 60.7% | 3 | 10.7% | 0 | .0% | 113.813** | .0001 | HS |
Grade III | 0 | .0% | 0 | .0% | 23 | 60.5% | 15 | 39.5% | ||||
Grade IV | 0 | .0% | 0 | .0% | 5 | 11.1% | 40 | 88.9% | ||||
Sex | Male | 5 | 6.8% | 13 | 17.6% | 25 | 33.8% | 31 | 41.9% | 6.151* | .104 | NS |
Female | 3 | 8.1% | 4 | 10.8% | 6 | 16.2% | 24 | 64.9% | ||||
Age group | <50 years | 6 | 10.9% | 11 | 20.0% | 18 | 32.7% | 20 | 36.4% | 8.19** | 0.04 | HS |
≥50 years | 2 | 3.6% | 6 | 10.7% | 13 | 23.2% | 35 | 62.5% | ||||
MIB group | <10.1 | 8 | 24.2% | 17 | 51.5% | 6 | 18.2% | 2 | 6.1% | 78.16* | .0001 | HS |
≥10.1 | 0 | .0% | 0 | .0% | 25 | 32.1% | 53 | 67.9% | ||||
Necrosis | 1 | 0 | 0% | 0 | 0% | 2 | 10.5% | 17 | 89.5% | 1.186** | 0.707 | NS |
2 | 0 | 0% | 0 | 0% | 3 | 16.7% | 15 | 83.3% | ||||
3 | 0 | 0% | 0 | 0% | 0 | 0% | 8 | 100% | ||||